StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVBW) stock

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30
$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Earnings

Revelation Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.87
-$7.01 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Revelation Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours––-$0.87Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours––-$2.71Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026during market hours––-$1.65Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours––-$1.77Release
Q2 FY2025ended Jun 30, 2025Aug 8, 2025before the open––-$7.01Release
Q1 FY2025ended Mar 31, 2025May 8, 2025during market hours––-$2.11Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025during market hours––-$4.98Release
Q3 FY2024ended Sep 30, 2024Nov 8, 2024during market hours––-$0.84Release
Q2 FY2024ended Jun 30, 2024Aug 9, 2024during market hours––-$5.13Release
Q1 FY2024ended Mar 31, 2024May 10, 2024during market hours––-$2.46Release
Q4 FY2023ended Dec 31, 2023Mar 22, 2024during market hours––-$8.33Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Revelation Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Revelation Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Revelation Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Revelation Biosciences, Inc. Announces Financial Results
    Results
  2. Revelation Biosciences Announces Adoption of Stockholder Rights Plan
    Update
  3. 8-K exhibit EX-99.1
    News
  4. Revelation Biosciences, Inc. Announces Financial Results
    Results
  5. Revelation Biosciences, Inc. Announces Financial Results
    Results
  6. Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
    News
  7. 8-K exhibit EX-99.2
    News
  8. 8-K exhibit EX-99.1
    News
  9. Revelation Biosciences, Inc. Announces Financial Results for the three and nine months ended September 30, 2025
    Results
  10. Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
    Update
  11. Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
    Update
  12. Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
    News
  13. Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
    News
  14. 8-K exhibit EX-99.2
    News
  15. Revelation Biosciences, Inc. Announces Financial Results for the three and six months ended June 30, 2025
    Results